Ontology highlight
ABSTRACT:
SUBMITTER: Brunetti A
PROVIDER: S-EPMC9228014 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
Brunetti Alessandro A Antonini Simone S Saladino Andrea A Lavezzi Elisabetta E Zampetti Benedetta B Cozzi Renato R
Medicina (Kaunas, Lithuania) 20220613 6
Somatostatin receptor ligands (SRLs) represent a true milestone in the medical therapy for acromegaly. The first-generation SRLs (FG-SRLs), octreotide and lanreotide, have demonstrated good efficacy in disease control and tumor shrinkage, and are still considered first-line medical therapies. The development of long-acting release (LAR) formulations has certainly improved the therapeutic tolerability of these drugs, although many patients still experience therapy-related burden. As such, new for ...[more]